Bionano Genomics, Inc.

BNGO

NASDAQ

Healthcare

Medical - Diagnostics & Research

San Diego, CA, US98 employeesbionanogenomics.com

$1.19

+0.00(0.00%)

Mkt Cap $4M

$1.09

$4.92

52-Week Range

At a Glance

AI-generated

Bionano Genomics, Inc.

Revenue breakdown: Product (47.6%), Consumable Revenue (23.7%), Instrument Revenue (12.7%).

$4M

Market Cap

$24M

Revenue

-$23M

Net Income

Employees98

Fundamentals

How The Business Makes Money

Revenue by Segment

Product47.6%($54M)

Consumable Revenue23.7%($27M)

Instrument Revenue12.7%($14M)

Software Revenue11.1%($13M)

Product And Service Other4.9%($6M)

Revenue by Geography

EMEA47.8%($28M)

Americas43.6%($26M)

Asia Pacific8.6%($5M)

Activity

What Changed Recently

Financial Results

Jan 11, 2026

of this Current Report on Form 8-K shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchang

Peer Companies

Company	Price	Change	Market Cap	P/E
VYNEVYNE Therapeutics Inc.	$0.61	+0.58%	$10M	-1.0
KTTAPasithea Therapeutics Cor...	$0.77	+3.49%	$6M	-0.4
QNRXQuoin Pharmaceuticals, Lt...	$6.96	+14.85%	$4M	-0.3
NDRAENDRA Life Sciences Inc.	$4.52	-2.80%	$3M	-0.3
POAIPredictive Oncology Inc.	$4.20	+17.98%	$3M	-0.0
MYNZMainz Biomed B.V.	$0.70	-5.07%	$3M	-0.0
AIMAIM ImmunoTech Inc.	$0.60	+9.05%	$2M	—
BNBXBNB Plus Corp.	$0.66	+0.58%	$847.8K	-0.2

Analyst View

Company Profile

CIK0001411690

ISINUS09075F4046

CUSIP09075F404

Phone858 888 7600

Address9540 Towne Centre Drive, San Diego, CA, 92121, US

SEC EDGAR